Top

Published in:

01-04-2017 | Note

Tubulin polymerization-stimulating activity of Ganoderma triterpenoids

Authors: Toshitaka Kohno, Tran Hai-Bang, Qinchang Zhu, Yhiya Amen, Seiichi Sakamoto, Hiroyuki Tanaka, Satoshi Morimoto, Kuniyoshi Shimizu

Published in: Journal of Natural Medicines | Issue 2/2017

Abstract

Tubulin polymerization is an important target for anticancer therapies. Even though the potential of Ganoderma triterpenoids against various cancer targets had been well documented, studies on their tubulin polymerization-stimulating activity are scarce. This study was conducted to evaluate the effect of Ganoderma triterpenoids on tubulin polymerization. A total of twenty-four compounds were investigated using an in vitro tubulin polymerization assay. Results showed that most of the studied triterpenoids exhibited microtuble-stabilizing activity to different degrees. Among the investigated compounds, ganoderic acid T-Q, ganoderiol F, ganoderic acid S, ganodermanontriol and ganoderic acid TR were found to have the highest activities. A structure–activity relationship (SAR) analysis was performed. Extensive investigation of the SAR suggests the favorable structural features for the tubulin polymerization-stimulating activity of lanostane triterpenes. These findings would be helpful for further studies on the potential mechanisms of the anticancer activity of Ganoderma triterpenoids and give some indications on the design of tubulin-targeting anticancer agents.

Cao Y, Wu S-H, Dai Y-C (2012) Species clarification of the prize medicinal Ganoderma mushroom “Lingzhi”. Fungal Divers 56:49–62. doi:10.1007/s13225-012-0178-5 CrossRef

Smina TP, Mathew J, Janardhanan KK, Devasagayam TPA (2011) Antioxidant activity and toxicity profile of total triterpenes isolated from Ganoderma lucidum (Fr.) P. Karst occurring in South India. Environ Toxicol Pharmacol 32:438–446. doi:10.1016/j.etap.2011.08.011 CrossRefPubMed

Sun J, He H, Bi JX (2004) Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. J Agric Food Chem 52:6646–6652. doi:10.1021/jf0495136 CrossRefPubMed

Zhu M, Chang Q, Wong LK et al (1999) Triterpene antioxidants from Ganoderma lucidum. Phytother Res 13:529–531CrossRefPubMed

Weng Y, Xiang L, Matsuura A et al (2010) Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene. Bioorg Med Chem 18:999–1002. doi:10.1016/j.bmc.2009.12.070 CrossRefPubMed

Fatmawati S, Kurashiki K, Takeno S et al (2009) The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum. Phytother Res 23:28–32. doi:10.1002/ptr.2425 CrossRefPubMed

Guo L, Xie J, Ruan Y et al (2009) Characterization and immunostimulatory activity of a polysaccharide from the spores of Ganoderma lucidum. Int Immunopharmacol 9:1175–1182. doi:10.1016/j.intimp.2009.06.005 CrossRefPubMed

Lin Z-B (2005) Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99:144–153. doi:10.1254/jphs.CRJ05008X CrossRefPubMed

Liu J, Shimizu K, Kondo R (2010) The effects of ganoderma alcohols isolated from Ganoderma lucidum on the androgen receptor binding and the growth of LNCaP cells. Fitoterapia 81:1067–1072. doi:10.1016/j.fitote.2010.06.029 CrossRefPubMed

10.

Ríos J-L, Andújar I, Recio M-C, Giner R-M (2012) Lanostanoids from fungi: a group of potential anticancer compounds. J Nat Prod 75:2016–2044. doi:10.1021/np300412h CrossRefPubMed

11.

Lee J, Hung T (2009) Steroids and triterpenoid from the fruit bodies of Ganoderma lucidum and their cytotoxic activity. Nat Prod Sci 15:173–179

12.

Wu T-S, Shi L-S, Kuo S-C (2001) Cytotoxicity of Ganoderma lucidum triterpenes. J Nat Prod 64:1121–1122. doi:10.1021/np010115w CrossRefPubMed

13.

Amen YM, Zhu Q, Tran H-B et al (2016) Lucidumol C, a new cytotoxic lanostanoid triterpene from Ganoderma lingzhi against human cancer cells. J Nat Med 70:661–666. doi:10.1007/s11418-016-0976-2 CrossRefPubMed

14.

Amen YM, Zhu Q, Afifi MS et al (2016) New cytotoxic lanostanoid triterpenes from Ganoderma lingzhi. Phytochem Lett. doi:10.1016/j.phytol.2016.07.024

15.

Lee MK, Hung TM, Cuong TD et al (2011) Ergosta-7,22-diene-2β,3α,9α-triol from the fruit bodies of Ganoderma lucidum induces apoptosis in human myelocytic HL-60 cells. Phytother Res 25:1579–1585. doi:10.1002/ptr.3447 CrossRefPubMed

16.

Wang J-H, Zhou Y-J, Zhang M et al (2012) Active lipids of Ganoderma lucidum spores-induced apoptosis in human leukemia THP-1 cells via MAPK and PI3 K pathways. J Ethnopharmacol 139:582–589. doi:10.1016/j.jep.2011.11.055 CrossRefPubMed

17.

Chen N-H, Zhong J-J (2009) Ganoderic acid Me induces G1 arrest in wild-type p53 human tumor cells while G1/S transition arrest in p53-null cells. Process Biochem 44:928–933. doi:10.1016/j.procbio.2009.03.018 CrossRef

18.

Tang W, Liu J-W, Zhao W-M et al (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci 80:205–211. doi:10.1016/j.lfs.2006.09.001 CrossRefPubMed

19.

Wu G-S, Lu J-J, Guo J-J et al (2012) Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia 83:408–414. doi:10.1016/j.fitote.2011.12.004 CrossRefPubMed

20.

Weng C-J, Chau C-F, Hsieh Y-S et al (2008) Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis 29:147–156. doi:10.1093/carcin/bgm261 CrossRefPubMed

21.

Chang U-M, Li C-H, Lin L-I et al (2006) Ganoderiol F, a ganoderma triterpene, induces senescence in hepatoma HepG2 cells. Life Sci 79:1129–1139. doi:10.1016/j.lfs.2006.03.027 CrossRefPubMed

22.

Li C-H, Chen P-Y, Chang U-M et al (2005) Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci 77:252–265. doi:10.1016/j.lfs.2004.09.045 CrossRefPubMed

23.

Liu J, Shimizu K, Tanaka A et al (2012) Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms. Sci Rep 2:905. doi:10.1038/srep00905 PubMedPubMedCentral

24.

Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265. doi:10.1038/nrc1317 CrossRefPubMed

25.

Cheng S, Sliva D (2015) Ganoderma lucidum for cancer treatment: we are close but still not there. Integr Cancer Ther. doi:10.1177/1534735414568721

Title: Tubulin polymerization-stimulating activity of Ganoderma triterpenoids
Authors: Toshitaka Kohno
Tran Hai-Bang
Qinchang Zhu
Yhiya Amen
Seiichi Sakamoto
Hiroyuki Tanaka
Satoshi Morimoto
Kuniyoshi Shimizu
Publication date: 01-04-2017
Publisher: Springer Japan
Published in: Journal of Natural Medicines / Issue 2/2017
Print ISSN: 1340-3443
Electronic ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-017-1072-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Tubulin polymerization-stimulating activity of Ganoderma triterpenoids

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

A novel lectin from Artocarpus lingnanensis induces proliferation and Th1/Th2 cytokine secretion through CD45 signaling pathway in human T lymphocytes

Lupinifolin from Derris reticulata possesses bactericidal activity on Staphylococcus aureus by disrupting bacterial cell membrane

Effects of oleuropein on pentylenetetrazol-induced seizures in mice: involvement of opioidergic and nitrergic systems

Antidepressant-like effects of ginsenoside Rg3 in mice via activation of the hippocampal BDNF signaling cascade

Partial contribution of Rho-kinase inhibition to the bioactivity of Ganoderma lingzhi and its isolated compounds: insights on discovery of natural Rho-kinase inhibitors

Inhibiting reactive oxygen species-dependent autophagy enhanced baicalein-induced apoptosis in oral squamous cell carcinoma